Holen Sie sich die Stockscreener-App
165.81
1.56%
2.5037
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ZTS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$163.31
Offen:
$162.77
24-Stunden-Volumen:
1.71M
Relative Volume:
0.79
Marktkapitalisierung:
$74.09B
Einnahmen:
$9.15B
Nettoeinkommen (Verlust:
$2.43B
KGV:
31.17
EPS:
5.32
Netto-Cashflow:
$2.31B
1W Leistung:
+2.23%
1M Leistung:
-6.01%
6M Leistung:
-5.20%
1J Leistung:
-14.88%
1-Tages-Spanne:
$162.04
$167.58
1-Wochen-Bereich:
$160.59
$167.58
52-Wochen-Spanne:
$144.80
$200.53
Zoetis Inc Stock (ZTS) Company Profile
Firmenname
Zoetis Inc
Sektor
Telefon
973-822-7000
Adresse
10 SYLVAN WAY, PARSIPPANY, NJ
Vergleichen Sie ZTS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
165.84 | 74.09B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.46 | 42.86B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.31 | 42.09B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.99 | 24.09B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.94 | 14.56B | 15.05B | -883.30M | 1.89B | -0.74 |
Zoetis Inc Stock (ZTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-12 | Bestätigt | Stifel | Buy |
| 2023-12-19 | Fortgesetzt | Jefferies | Buy |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-03-08 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-08-14 | Hochstufung | Edward Jones | Hold → Buy |
| 2020-08-12 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-05-27 | Eingeleitet | Jefferies | Buy |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-09-09 | Eingeleitet | Goldman | Buy |
| 2019-07-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2019-05-03 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-04 | Hochstufung | Stifel | Hold → Buy |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-10-15 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-22 | Herabstufung | Stifel | Buy → Hold |
| 2018-08-03 | Bestätigt | Stifel | Buy |
| 2018-04-19 | Bestätigt | Citigroup | Buy |
| 2018-03-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | Bestätigt | Stifel | Buy |
| 2018-01-04 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Zoetis Inc Aktie (ZTS) Neueste Nachrichten
AHP launches sixth equine industry survey, sponsored by Zoetis - EQUUS Magazine
Pensionfund Sabic Has $1.83 Million Stock Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Nordea Investment Management AB Buys 572,511 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Equine Healthcare Market Size, Competitive Outlook Zoetis, Kyoritsu Seiyaku, Vetoquinol, Boehringer Ingelheim, Virbac - openPR
Pet Health Screening Market Future Business Opportunities - openPR
Everence Capital Management Inc. Reduces Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wrap up: Artificial intelligence and its role in veterinary medicine, and other veterinary news - DVM 360
Zoetis Inc. stock rises Friday, still underperforms market - MarketWatch
GAMMA Investing LLC Acquires 3,165 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
AHP Launches Sixth Equine Industry Survey, Sponsored by Zoetis - TheHorse.com
Zoetis to Acquire Animal Health Assets of Abbott - Farm Progress
GeneDx appoints former Zoetis general counsel as legal chief - | Governance Intelligence
Zoetis (ZTS) is a Top-Ranked Growth Stock: Should You Buy? - MSN
Is Zoetis Inc. (ZTS) the Best Pharma Dividend Stock to Buy In 2024? - Insider Monkey
13 Best Pharma Dividend Stocks To Buy In 2024 - Insider Monkey
Pet Medication Market Projected To Witness Substantial Growth, 2024-2031: Zoetis, Merck, Elanco, Bayer, - EIN News
JPMorgan Chase & Co. Grows Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
ZTS: Is Zoetis a Smart Investment in the Pharmaceuticals Sector? - StockNews.com
ZTS: 3 Healthcare Innovators with Analyst-Endorsed Upside - StockNews.com
Zoetis Inc. (ZTS): A Bull Case Theory - MSN
The Wall Street Journal Vs. Zoetis (ZTS) - Seeking Alpha
Zoetis Inc. stock rises Tuesday, still underperforms market - MarketWatch
Zoetis Inc. (NYSE:ZTS) Shares Sold by M&T Bank Corp - MarketBeat
Here's Why Zoetis (ZTS) Gained But Lagged the Market Today - MSN
Livestock Drug Market to See Stunning Growth with Zoetis, Elanco, Bayer Animal Health - openPR
Zoetis Inc. (NYSE:ZTS) Receives $215.22 Consensus PT from Brokerages - MarketBeat
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zoetis is Now Oversold (ZTS) - Nasdaq
📈 Is Zoetis a good stock to buy? - substack.com
Earnings growth of 2.9% over 3 years hasn't been enough to translate into positive returns for Zoetis (NYSE:ZTS) shareholders - Simply Wall St
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive Income - The Motley Fool
Zoetis dips as FDA cites adverse events linked to canine pain therapy Librela - MSN
Zoetis donates $100,000 to support vet mental health - Vet Practice magazine
Elliott Wave Pattern Puts Zoetis Bulls On Alert - EWM Interactive
Zoetis stock dips after FDA notice on Librela (ZTS:NYSE) - Seeking Alpha
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet? - Yahoo Finance
Zoetis Issues Vaccine Reminder for Pregnant Broodmares in Third Trimester - EQUUS Magazine
Here's Why Zoetis (ZTS) is a Strong Growth Stock - Yahoo Finance
American Trust Sells 4,044 Shares of Zoetis Inc. (NYSE:ZTS) - MarketBeat
Wilmington Savings Fund Society FSB Increases Stock Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
World Investment Advisors LLC Has $6.69 Million Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Zoetis Inc. (NYSE:ZTS) Stake Lessened by Sanctuary Advisors LLC - MarketBeat
Podcast: Harness Culture to Drive Value with Zoetis’ Supply Chain EVP - Gartner
Zoetis Boosts Dividend by 16% for 2025 - TipRanks
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase - Business Wire
Stock Yards Bank & Trust Co. Lowers Stake in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Toronto Dominion Bank Increases Position in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Veterinary Pain Management Market Is Booming Worldwide - openPR
Zoetis Boosts Quarterly Dividend by 16% to Record $0.50, Showcases Strong Financial Performance - StockTitan
Why Zoetis Inc. (NYSE:ZTS) Looks Like A Quality Company - Yahoo Finance
TCW Group Inc. Has $123.40 Million Holdings in Zoetis Inc. (NYSE:ZTS) - MarketBeat
Finanzdaten der Zoetis Inc-Aktie (ZTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):